Key cardiovascular and metabolic conditions include: Hypertension particularly nocturnal hypotension or poorly controlled blood pressure Diabetes mellitus both type 1 and type 2, with microvascular complications Hyperlipidemia contributing to atherosclerotic vascular disease Obstructive sleep apnea causing intermittent hypoxia and hemodynamic fluctuations Coronary artery disease reflecting systemic atherosclerosis Smoking promoting endothelial dysfunction and vascular disease Age represents an independent risk factor, with NAION incidence increasing significantly after 50 years
Weight management : Continue working towards weight loss goals, as sustained weight reduction provides ongoing benefits to lipid metabolism and cardiovascular risk
Direct Meds prices their injectable semaglutide at approximately $297 per month
The article states that FDA approval for weight management covers adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension or type 2 diabetes
However, if the pill form is much weaker , doctors may still recommend injections for the best results
Free from common allergens and formulated with minimal excipients